Duke Medicine’s Health News (HN)

logo

Volume 21   •   Number 9  •  September 2015

More Effective Heart-Failure Drug in the Works

Cardiologists are closely watching clinical trials of the first new drug in years to treat heart failure. The drug—known only as LCZ696—is the first in a brand-new class of medications called angiotensin-receptor blockers/neprilysin inhibitors (ARNIs). These drugs use a unique mode of action to relax blood vessels and eliminate excess fluid …


Issue Highlights

Subscribe Now

Editor-in-Chief
Dan G. Blazer, MD, PhD
J.P. Gibbons Professor Emeritus of Psychiatry & Behavioral Sciences; Professor, Department of Community and Family Medicine,
Duke University Medical Center
Associate Editor
Associate Editor
Thomas M. Bashore, MD, Professor, Medicine-Cardiology,
Duke University Medical Center
Editor
Diane Muhlfeld
Creative Director
Judi Crouse
Publisher
Timothy H. Cole
Editorial Advisory Board
Connie Bales, PhD
Professor,
Medicine-Geriatrics

Diana B. McNeill, MD, FACP
Professor,
Medicine-Endocrinology

Jeffrey Crawford, MD
Professor,
Medicine-Oncology

William E. Garrett, Jr., MD
Professor,
Orthopedic Surgery

Enter Your Log In Credentials
This setting should only be used on your home or work computer.

×